Glibenclamide vs acarbose ‐ neonatal outcomes
Neonatal hypoglycaemia · women with gestational diabetes mellitus
Glibenclamide showed no clear difference in neonatal hypoglycaemia compared with acarbose ‐ neonatal outcomes (low certainty).
1 finding from 1 review
- Oral anti‐diabetic pharmacological therapies for the treatment of women with gestational diabetes 2017 · Cochrane Headline outcomes onlyRR 6.33 [0.87, 46.32]1 study · 43 participantsLow